growth hormone receptor
Last updated 26 Jul 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The GHR gene provides instructions for making a protein called the growth hormone receptor. This receptor is embedded in the outer membrane of cells throughout the body and is most abundant in liver cells.
Video picks for GenesVideo library
Normal function
The GHR gene provides instructions for making a protein called the growth hormone receptor. This receptor is embedded in the outer membrane of cells throughout the body and is most abundant in liver cells.
The growth hormone receptor has three major parts: An extracellular region that sticks out from the surface of the cell, a transmembrane region that anchors the receptor to the cell membrane, and an intracellular region that transmits signals to the interior of the cell. The extracellular region attaches (binds) to a substance called growth hormone, fitting together like a lock and its key. The binding of growth hormone triggers signaling via the intracellular region of the receptor that stimulates the growth and division of cells. This signaling also leads to the production, primarily by liver cells, of another important growth-promoting hormone called insulin-like growth factor I (IGF-I).
Growth hormone and IGF-I have a wide variety of effects on the growth and function of many parts of the body. For example, these hormones stimulate the growth and division of cells called chondrocytes, which play a critical role in producing new bone tissue. Growth hormone and IGF-I also influence metabolism, including how the body uses and stores carbohydrates, proteins, and fats from food.
Researchers have identified two major versions (isoforms) of the growth hormone receptor. The two isoforms differ by the presence or absence of a particular segment known as exon 3, which is located in the extracellular region of the receptor. The version of the receptor that includes exon 3 is known as the full-length isoform (fl-GHR), while the version that is missing exon 3 is known as the exon 3-deficient isoform (d3-GHR). Both isoforms are relatively common in most populations. Each individual can have fl-GHR only, d3-GHR only, or a mix of both isoforms. The two isoforms bind to growth hormone in the same way on the surface of cells, but for reasons that are unclear, d3-GHR is associated with enhanced signaling within cells compared with fl-GHR.
Conditions referring to this gene or chromosome
Other names
GH receptor
GHBP
GHR_HUMAN
growth hormone binding protein
serum binding protein
somatotropin receptor
Patient picks for Genes

Hormones
Do you need a hormone imbalance test?
If your hormones are out of balance, your body may show certain symptoms or changes. The best way to check for a hormone imbalance is by talking to your doctor, who may recommend you for a test. In this article, we look at what a hormone imbalance test involves, the common symptoms, and explore potential health issues linked to hormonal imbalances.
by Victoria Raw

Hormones
Pituitary gland disorders
This leaflet gives a brief overview of the pituitary gland and the hormones it makes. The pituitary gland is found at the base of the brain and is 'pea-sized'. The pituitary gland is an overall controller of a number of other glands in the body, overseeing the function of these organs through hormones.
by Dr Hayley Willacy, FRCGP

Children's health
Restricted growth
Dwarfism is a medical or genetic condition which causes people to have restricted growth so that they are shorter than average. Specifically, people with dwarfism grow no higher than 4 ft 10 ins (147 cm). It can be due to literally hundreds of different causes, so the term actually includes many different medical conditions. The cause and type of dwarfism will therefore affect the outlook and problems that may be associated with it. The most common condition causing dwarfism is achondroplasia.
by Dr Hayley Willacy, FRCGP

Men's health
Is 'male menopause' real?
Menopause is a natural stage of life that women go through as they age. During this time, their reproductive hormone levels fluctuate and gradually decline, causing a range of physical and emotional symptoms. But can men experience something similar? Often referred to as ‘male menopause’, hormonal changes as men get older can also affect their health and wellbeing. We explore the symptoms, causes, and science behind 'male menopause' and why it deserves more attention.
by Victoria Raw

Hormones
Acromegaly
Acromegaly is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. The most noticeable symptoms are that your hands and feet become larger and features of your face may become more prominent. The cause is usually a small non-cancerous growth (tumour) in the pituitary gland. Treatment options include surgery to remove the growth and medicines to block the release or effects of growth hormone.
by Dr Mohammad Sharif Razai, MRCGP

Hormones
Insulin resistance: the common thread linking metabolic conditions
You may have come across the term “insulin resistance” - particularly if you’ve been having conversations about weight and metabolic health - but be a little unclear about what it actually is. Whilst it’s easy to think insulin resistance just means reduced glucose control, it’s actually far more complex than that. Dr Nienke Lees, Women's Health Service Lead, Genwell UK, explains what it means and how it connects conditions including type 2 diabetes, fatty liver disease, cardiovascular disease, and PCOS.
by Dr Nienke Lees
Related patient information and medicines

Patient information leaflet
Breast cancer
Dr Sarah Jarvis MBE If left untreated, cancers often go through three stages: local growth, spread to lymph channels and spread to other areas of the body. ...tion on the stages of cancer, go to [https://patient.info/health/cancer/stages-of-cancer](https://patient.info/health/cancer/stages-of-cancer) Like any other cancer, breast cancer can be.

Patient information leaflet
Pituitary gland disorders
This leaflet gives a brief overview of the pituitary gland and the hormones it makes. The pituitary gland is found at the base of the brain and is 'pea-sized'. Cushing's syndrome Prolactinoma. Prolactinoma Conditions where the pituitary gland fails to produce enough hormones include: Adult growth hormone deficiency. Diabetes insipidus Diabetes.

Patient information leaflet
Restricted growth
Dwarfism is a medical or genetic condition which causes people to have restricted growth so that they are shorter than average. Disorders which affect hormones (particularly growth hormone), major organs (for example, kidney diseases), bones or the body's general functioning (metabolism) can slow growth. Treatment that might be relevant includes:.

Patient information leaflet
Acromegaly
Acromegaly is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. See separate leaflet called G... Rarely, acromegaly is caused by an overproduction of a hormone called growth hormone-releasing hormone (GHRH), which comes from the hypothalamus in.

Patient information leaflet
Fibroids
A fibroid is a non-cancerous (benign) growth of the womb (uterus). They are also called uterine myomas, fibromyomas or leiomyomas. Dr Lesley Regan Fibroids are common and usually cause no symptoms. Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist, so works like the medication above. This is then combined with the oestrogen,.

Patient information leaflet
Adrenarche
This leaflet was originally provided by Miriam Leach (written when a 4th year MB ChB student at Manchester University), used here with permission. Adrenarche (ad-ren-ar-ke) is known to be an ordinary bodily process that happens to boys and girls as they begin to make the transition to being a teenager. ...Adrenarche image On top of the kidneys is.
Further reading and references
- growth hormone receptor; MedlinePlus, National Library of Medicine.
- Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay MC, Goossens M. Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med. 1989 Oct 12;321(15):989-95. doi: 10.1056/NEJM198910123211501.
- Brooks AJ, Waters MJ. The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol. 2010 Sep;6(9):515-25. doi: 10.1038/nrendo.2010.123. Epub 2010 Jul 27.
- Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet. 2004 Jul;36(7):720-4. doi: 10.1038/ng1379. Epub 2004 Jun 20.
- Filopanti M, Giavoli C, Grottoli S, Bianchi A, De Marinis L, Ghigo E, Spada A. The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions. J Endocrinol Invest. 2011 Dec;34(11):861-8. doi: 10.1007/BF03346731.
- Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011 Feb 16;3(70):70ra13. doi: 10.1126/scitranslmed.3001845.
- Guevara-Aguirre J, Rosenbloom AL. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency. Diabetologia. 2015 Jan;58(1):37-42. doi: 10.1007/s00125-014-3397-3. Epub 2014 Oct 15.
- Jorge AA, Arnhold IJ. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment. Horm Res. 2009 Apr;71 Suppl 2:55-63. doi: 10.1159/000192438. Epub 2009 Apr 29.
- Savage MO, Woods KA, Johnston LB, Postel-Vinay MC, Amselem S, Clark AJ. Defects of the growth hormone receptor and their clinical implications. Growth Horm IGF Res. 1999 Apr;9 Suppl A:57-61. doi: 10.1016/s1096-6374(99)80011-2. No abstract available.
- Wassenaar MJ, Biermasz NR, Pereira AM, van der Klaauw AA, Smit JW, Roelfsema F, van der Straaten T, Cazemier M, Hommes DW, Kroon HM, Kloppenburg M, Guchelaar HJ, Romijn JA. The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly. J Clin Endocrinol Metab. 2009 Dec;94(12):4671-8. doi: 10.1210/jc.2009-1172. Epub 2009 Oct 28.
- Wassenaar MJ, Dekkers OM, Pereira AM, Wit JM, Smit JW, Biermasz NR, Romijn JA. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2009 Oct;94(10):3721-30. doi: 10.1210/jc.2009-0425. Epub 2009 Jul 7.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

